Authors | Level of Evidence | Design | Cases | Mean age (y, range) | Mean FU (m, range) | Range of motion | Outcome measurements |
---|---|---|---|---|---|---|---|
Cemented all-polyethylene glenoid components (PEG) | |||||||
 Raiss (2008) | IV | Aequalisa | 21 | 55 (37–60) | 7 years (5–9) | FE, ABD, IR, ER | Constant score |
 Rice (2008) | IV | Cofield IIb | 14 | 66 (52–78) | 5 years (2–8) | ABD, ER | Neer result rating |
 Fox (2009) | IV | Mixedc | 972 | 66.4 | 68.1 | N | N |
 Edwards (2010) | I | Aequalisa | 47 | 69 ± 11 | 26 (12–38) | N | N |
 Throckmorton (2010) | III | Cofield | 100 | 68.6 (52–80) | 48.5 (24–98) | FE, IR, ER | VAS |
 Arnold (2011) | IV | Global Advantaged | 35 | 70 (49–89) | 43 (24–66) | N | Constant score |
 Collin (2011) | II | Aequalisa | 56 | 66.7 (43–83) | 120 (102–155) | N | N |
 Walch (2011) | IV | Aequalisa | 333 | 69.3 (35–90) | 89.5 (61–152) | FE, ER | Constant score |
 Young (2011) | IV | Aequalisa | 226 | 66.9 (40–90) | 122.7 (61–219) | FE, ER | Constant score |
 Raiss (2012) | IV | Aequalisa | 39 | 64 (43–79) | 132 (120–180) | FE, ABD, IR, ER | Constant score |
 Wirth (2012) | IV | Global Advantaged | 44 | 66 (52–79) | 48 (24–84) | FE, IR, ER | VAS, ASES score, SST |
 Denard (2013) | IV | Aequalisa | 50 | 50.5 (35–55) | 115.5 (60–211) | FE, ER | Constant score |
 Greiner (2013) | IV | Affinise | 97 | 66.6 (30–85) | 58.8 (31.2–92.5) | FE, ABD | Constant score |
 Raiss (2014) | IV | N (mixed) | 329 | N | 8.0 years (4–17) | FE, ER | Constant score |
 Gazielly (2015) | IV | Aequalisa | 39 | 68.1 (51–81) | 102 (56.4–150) | FE, ER | Constant score, pain score |
 Gulotta (2015) | III | BioModularf | 40 | 68.2 ± 9.1 | 38 (24–45) | N | VAS, ASES |
 Noyes (2015) | IV | Global Advantaged | 42 | 64 (51–80) | 80 (63–114) | FE, ER | ASES |
 Wright (2015) | IV | Equinoxeg | 24 | 66.4 ± 9.1 | 29.6 ± 8.7 | FE, ABD, IR, ER | Constant score, ASES, SST, UCLA |
 Parks (2016) | IV | Affinitih | 76 | 63.5 (39–86) | 28.7 (24–60) | FE, ABD, IR, ER | Constant score, ASES |
 Wijeratna (2016) | IV | Global Advantaged | 83 | 68.6 (49–88) | 46.7 (24–99) | FE, IR, ER | ASES, Oxford score |
 McLendon (2017) | IV | Cofield IIi | 287 | 65 (21–85) | 84 (48–171.6) | N | N |
 Service (2017) | III | Global Advantaged | 71 | 68 ± 8.3 | 30 ± 7.2 | N | SST |
 Gauci (2018) | III | Aequalisa | 46 | 55(40–60) | 123.6 ± 26 (60–144) | FE, ER | VAS, Constant score, SSV |
 Raiss (2018) | IV | Aequalisj | 118 | 68 (51–85) | 38 (24–70) | N | N |
 Sanchez-Sotelo (2018) | 2018/IV | PEG | 202 | 67 (24–93) | 32.4 (24–60) | FE, IR, ER | ASES |
Modern design of metal-backed glenoid component (MBG) | |||||||
 Castagna (2010) | IV | Second-generation SMRl | 35 | 62.7 (55.3–70.1) | 75.4 | N | VAS, Constant score, SST |
 Fucentese (2010) | IV | Sulmeshm | 22 | 68.5 (49–84) | 50 (24–89) | N | Constant score |
 Budge (2013) | IV | Tantalum TMn | 19 | 62.8 ± 14.6 | 31 (24–64) | ER | VAS, ASES score |
 Styron (2016) | IV | Tantalum TMn | 66 | 66.2 (31–88) | 50.2 | FE, IR, ER | N |
 Sandow (2016) | IV | Tantalum TMn | 10 | (60–79) | 24 | FE | VAS, Oxford score, ASES score |
 Panti (2016) | IV | Tantalum TMn | 76 | 69.6 (52–81) | 43.2 (24–72) | FE, ABD, ER | VAS, ASES score |
 Endrizzi (2016) | IV | Tantalum TMn | 73 | 67.5 ± 8.6 (46–85) | 50.8 (24–68) | N | VAS, ASES score |
 Merolla (2016) | IV | Tantalum TMn | 40 | 63.8 (40–75) | 38 (24–42) | FE, ABD, ER | Health state, Constant score, ASES score |
 Gurin (2017) | IV | Tantalum TMn | 80 | N | 100 | N | VAS |
 Watson (2018) | IV | Tantalum TMn | 36 | 66.36 (50–85) | 34.1 (23–61) | FE, ER | VAS, SANE score, Penn score, ASES score |
Common outcome measurements | Radiolucency, loosening, complication, and revision surgery (failure) |